Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response

Affiliations

¹ Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada.
² Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.
³ Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON, M5G 1X5, Canada.
⁴ Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
⁵ Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC, H3T 1J4, Canada.
⁶ Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
⁷ Terry Fox Molecular Oncology Group and Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research and Departments of Oncology and Medicine, McGill University, Montreal, QC, H3T 1E2, Canada.
⁸ Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 2M9, Canada.
⁹ Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. nara@pharm.or.jp.
¹⁰ Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada. d.barsyte@utoronto.ca.
¹¹ Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada. d.barsyte@utoronto.ca.
¹² Nature Research Center, Vilnius, Akademijos 2, Lithuania. d.barsyte@utoronto.ca.

^# Contributed equally.

Published Erratum

Magdalena M Szewczyk et al. Nat Commun. 2020.

. 2020 May 26;11(1):2683.

doi: 10.1038/s41467-020-16613-x.

¹ Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada.
² Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.
³ Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON, M5G 1X5, Canada.
⁴ Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
⁵ Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC, H3T 1J4, Canada.
⁶ Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
⁷ Terry Fox Molecular Oncology Group and Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research and Departments of Oncology and Medicine, McGill University, Montreal, QC, H3T 1E2, Canada.
⁸ Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 2M9, Canada.
⁹ Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. nara@pharm.or.jp.
¹⁰ Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada. d.barsyte@utoronto.ca.
¹¹ Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada. d.barsyte@utoronto.ca.
¹² Nature Research Center, Vilnius, Akademijos 2, Lithuania. d.barsyte@utoronto.ca.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.
Szewczyk MM, Ishikawa Y, Organ S, Sakai N, Li F, Halabelian L, Ackloo S, Couzens AL, Eram M, Dilworth D, Fukushi H, Harding R, Dela Seña CC, Sugo T, Hayashi K, McLeod D, Zepeda C, Aman A, Sánchez-Osuna M, Bonneil E, Takagi S, Al-Awar R, Tyers M, Richard S, Takizawa M, Gingras AC, Arrowsmith CH, Vedadi M, Brown PJ, Nara H, Barsyte-Lovejoy D. Szewczyk MM, et al. Nat Commun. 2020 May 14;11(1):2396. doi: 10.1038/s41467-020-16271-z. Nat Commun. 2020. PMID: 32409666 Free PMC article.